Venus Remedies Limited (BOM:526953)
947.55
-31.20 (-3.19%)
At close: May 5, 2026
Venus Remedies Market Cap
Venus Remedies has a market cap or net worth of 12.36 billion as of May 6, 2026. Its market cap has increased by 196.74% in one year.
Market Cap
12.36B
Enterprise Value
10.14B
Revenue
7.03B
Ranking
n/a
PE Ratio
16.20
Stock Price
947.55
Market Cap Chart
Since October 19, 2004, Venus Remedies's market cap has increased from 242.83M to 12.36B, an increase of 4,989.01%. That is a compound annual growth rate of 19.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 12.36B | 20.53% |
| Dec 31, 2025 | 10.25B | 139.58% |
| Dec 31, 2024 | 4.28B | -21.14% |
| Dec 29, 2023 | 5.43B | 124.10% |
| Dec 30, 2022 | 2.42B | -55.77% |
| Dec 31, 2021 | 5.48B | 194.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kwality Pharmaceuticals | 17.19B |
| Amrutanjan Health Care | 16.68B |
| Lincoln Pharmaceuticals | 13.66B |
| Fredun Pharmaceuticals | 13.37B |
| Shukra Pharmaceuticals | 13.36B |
| Syncom Formulations (India) | 13.22B |
| TTK Healthcare | 12.82B |
| Wanbury | 8.79B |